Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D007939:Leukemia L1210 / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012516:Osteosarcoma / Q000188:drug therapy*; D012510:Sarcoma 180 / Q000188:drug therapy*; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014499:Uracil Mustard / Q000627:therapeutic use*